CHARLOTTETOWN, Canada—Bone mineral density (BMD) testing and bisphosphonate use are significantly underused in men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa), a new study ...

Sept. 28, 20005 (Nashville) — Most women aged 65 years and older do not require repeat bone mineral density (BMD) tests to determine their fracture risk, according to a presentation at the American ...

Objective: Bone mineral density (BMD) testing is a key tool used to diagnose and treat osteoporosis. We assessed the rate of scheduling BMD tests among health plan members at risk for osteoporosis who ...

Repeat bone mineral density (BMD) testing did not improve fracture-risk prediction in a large prospective cohort of postmenopausal women beyond baseline BMD measurement alone, according to new 12-year ...

Bone mineral density (BMD) testing is used to diagnose osteoporosis, assess fracture risk and monitor changes in BMD over time. A variety of devices and technologies are used to measure BMD or other ...

Based on emerging evidence and expert opinion, a task force put together by the International Society for Clinical Densitometry created position statements on the assessment of BMD in transgender and ...

This multicenter, randomized controlled trial involved 436 women, aged 50-85 years, who had attended hospital for treatment of a fragility fracture of the wrist or upper arm. The intervention group ...

Aromatase inhibitors (AIs)—drugs that stop the production of estrogen in women—are standard adjuvant therapy for post-menopausal women with hormone-receptor positive breast cancer. AIs are an ...